EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy

Chang Gung Memorial Hospital100 enrolled

Overview

This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.

A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Mediastinal Lymphadenopathy Lung Cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years old * mediastinal lymphadenopathy on Chest CT scan * with a short-axis \> 10mm Exclusion Criteria: * patients intolerant to bronchoscopy exam * unstable vital sign (Blood pressure, heart rate, breath rate)

Locations (1)

Chang Gung Memorial Hospital

Taipei, Taipei, Taiwan

RECRUITING

Outcomes

Primary Outcomes

Diagnostic rate

Time frame: Participant will be followed within an average of three months

Central Contacts

Chih-Hsi Kuo, MD

CONTACT

chihhsikuo@gmail.com

Fu-Tsai Chung, MD

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.